Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nephros (NEPH) EBITDA (2016 - 2025)

Historic EBITDA for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $314000.0.

  • Nephros' EBITDA rose 5242.72% to $314000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 25471.09%. This contributed to the annual value of $6000.0 for FY2024, which is 10038.1% up from last year.
  • Latest data reveals that Nephros reported EBITDA of $314000.0 as of Q3 2025, which was up 5242.72% from $248000.0 recorded in Q2 2025.
  • Nephros' EBITDA's 5-year high stood at $566000.0 during Q1 2025, with a 5-year trough of -$3.2 million in Q3 2022.
  • In the last 5 years, Nephros' EBITDA had a median value of -$433000.0 in 2023 and averaged -$627526.3.
  • Its EBITDA has fluctuated over the past 5 years, first tumbled by 23770.76% in 2022, then soared by 43491.12% in 2025.
  • Nephros' EBITDA (Quarter) stood at -$1.1 million in 2021, then increased by 15.93% to -$929000.0 in 2022, then rose by 29.6% to -$654000.0 in 2023, then soared by 148.47% to $317000.0 in 2024, then fell by 0.95% to $314000.0 in 2025.
  • Its last three reported values are $314000.0 in Q3 2025, $248000.0 for Q2 2025, and $566000.0 during Q1 2025.